Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPSTONE 1: Baloxavir Marboxil in Uncomplicated Influenza
NCT02954354Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of baloxavir marboxil in influenza (5 arms), sponsored by Shionogi & Co., Ltd. Primary endpoint: Time to Alleviation of Symptoms. Started Dec 2016; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02954354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02954354.